日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fecal Microbiota Transplantation by Rectal Enema Improves Short-Term Insulin Resistance in Metabolic Syndrome: A Pilot Randomized Controlled Trial

粪便微生物群灌肠移植改善代谢综合征患者的短期胰岛素抵抗:一项初步随机对照试验

Piwchan, Setthachai; Aumpan, Natsuda; Chonprasertsuk, Soonthorn; Pornthisarn, Bubpha; Siramolpiwat, Sith; Bhanthumkomol, Patommatat; Nunanan, Pongjarat; Issariyakulkarn, Navapan; Wongcha-Um, Arti; Miftahussurur, Muhammad; Mahachai, Varocha; Yamaoka, Yoshio; Vilaichone, Ratha-Korn

Efficacy of fourteen-day once-daily vonoprazan-based quadruple therapy for Helicobacter pylori in high clarithromycin-resistance regions (ONCE-VONO Trial)

在克拉霉素耐药性高的地区,以伏诺拉生为基础的四联疗法治疗幽门螺杆菌感染的14天疗效(ONCE-VONO试验)

Sukkamolsantiporn, Saran; Bongkotvirawan, Phubordee; Chonprasertsuk, Soonthorn; Pornthisarn, Bubpha; Siramolpiwat, Sith; Bhanthumkomol, Patommatat; Issariyakulkarn, Navapan; Gamnarai, Pornpen; Wongcha-Um, Arti; Aumpan, Natsuda; Vilaichone, Virunpat; Sornchuer, Phornphan; Mahachai, Varocha; Miftahussurur, Muhammad; Yamaoka, Yoshio; Kitipawong, Peerapong; Vilaichone, Ratha-Korn

Efficacy of encapsulated fecal microbiota transplantation and FMT via rectal enema for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial (CAP-ENEMA FMT Trial)

经直肠灌肠进行封装粪便微生物移植和 FMT 治疗肠易激综合征的疗效:一项双盲、随机、安慰剂对照试验(CAP-ENEMA FMT 试验)

Aumpan, Natsuda; Chonprasertsuk, Soonthorn; Pornthisarn, Bubpha; Siramolpiwat, Sith; Bhanthumkomol, Patommatat; Issariyakulkarn, Navapan; Gamnarai, Pornpen; Bongkotvirawan, Phubordee; Wongcha-Um, Arti; Mahachai, Varocha; Vilaichone, Ratha-Korn

Simultaneous detection of Helicobacter pylori infection comparing between white light and image-enhanced endoscopy

同时检测幽门螺杆菌感染:白光内镜与图像增强内镜的比较

Chatrangsun, Boonyaorn; Aumpan, Natsuda; Pornthisarn, Bubpha; Chonprasertsuk, Soonthorn; Siramolpiwat, Sith; Bhanthumkomol, Patommatat; Nunanan, Pongjarat; Issariyakulkarn, Navapan; Mahachai, Varocha; Yamaoka, Yoshio; Vilaichone, Ratha-Korn

Predictive Factors Associated with Survival in Female Gastric Cancer Patients in Southeast Asia

东南亚女性胃癌患者生存率的预测因素

Bongkotvirawan, Phubordee; Aumpan, Natsuda; Pornthisarn, Bubpha; Chonprasertsuk, Soonthorn; Siramolpiwat, Sith; Bhanthumkomol, Patommatat; Nunanun, Pongjarat; Issariyakulkarn, Navapan; Mahachai, Varocha; Pawa, Kammal Kumar; Vilaichone, Ratha-Korn

Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial)

幽门螺杆菌治疗失败的管理:一项基于人群的大型研究(HP治疗失败试验)

Aumpan, Natsuda; Issariyakulkarn, Navapan; Mahachai, Varocha; Graham, David; Yamaoka, Yoshio; Vilaichone, Ratha-Korn

Branched-chain amino acids supplementation improves liver frailty index in frail compensated cirrhotic patients: a randomized controlled trial

支链氨基酸补充剂可改善虚弱代偿期肝硬化患者的肝脏脆弱指数:一项随机对照试验

Siramolpiwat, Sith; Limthanetkul, Nisakorn; Pornthisarn, Bubpha; Vilaichone, Ratha-Korn; Chonprasertsuk, Soonthorn; Bhanthumkomol, Patommatat; Nunanan, Pongjarat; Issariyakulkarn, Navapan

Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study

乳酸杆菌R0011和瑞士乳杆菌R0052作为幽门螺杆菌根除辅助剂的疗效和安全性:一项双盲、随机、安慰剂对照研究

Kiattiweerasak, Anya; Aumpan, Natsuda; Chonprasertsuk, Soonthorn; Pornthisarn, Bubpha; Siramolpiwat, Sith; Bhanthumkomol, Patommatat; Nunanan, Pongjarat; Issariyakulkarn, Navapan; Mahachai, Varocha; Yamaoka, Yoshio; Vilaichone, Ratha-Korn